GMO is a Boston asset manager co-founded in 1977 by Jeremy Grantham with Richard Mayo and Eyk Van Otterloo, known for valuation-driven dynamic asset allocation built on long-horizon mean reversion. Grantham is famous for calling historic bubbles, warning publicly ahead of both the 2000 dot-com crash and the 2008 financial crisis. Flagship publications include the GMO Quarterly Letter (now written by Asset Allocation co-heads Ben Inker and John Pease), Grantham's Viewpoints essays and the 7-Year Asset Class Forecast.

This report says that after the 2022 market crash, some assets have become cheap and might be good buys. For example, hot stuff like crypto and growth stocks crashed, while unloved assets like commodities and value stocks actually rose. For regular investors, this means looking at cheap assets like emerging market stocks and deep value U.S. stocks, which could offer good long-term returns. But the overall U.S. market isn't cheap yet, and more volatility is possible. The key takeaway: buying cheap assets is better than chasing trends, but it requires patience.
The financial markets endured a painful year in 2022, with nearly all traditional assets posting significant losses, and only a few strategies that had long been out of favor achieving positive returns. The distribution of losses is highly correlated with the extreme valuations seen during the 2020–
This chapter discusses the broad decline in financial markets in 2022 and the investment opportunities it created. Author Ben Inker argues that the COVID-19 "FOMO" (Fear of Missing Out) bull market of 2020-2021 was the most severe speculative frenzy since the 1999-2000 internet bubble, and that the 2022 market correction has significantly lowered asset prices, creating a buying window for investors not seen in years.
The author's core investment argument is: 2022 was a "JOMO" (Joy of Missing Out) market, where declines in relatively cheap assets typically create buying opportunities. Counterintuitive judgments include:
The author supports the argument with performance data for various asset classes in 2022, ranked from highest to lowest "FOMO" level:
| Asset/Strategy | 2022 Return | Group Average Return | Category |
|---|---|---|---|
| S&P Crypto Broad Digital Market | -69.9% | -52.3% | Deep FOMO |
| ARK Innovation ETF | -67.0% | ||
| MEME ETF | -62.1% | ||
| Nasdaq | -33.1% | -21.0% | FOMO |
| S&P 500 Growth | -29.4% | ||
| Bloomberg U.S. Long Govt/Credit | -27.1% | ||
| MSCI Emerging Growth | -24.0% | ||
| S&P U.S. REIT | -24.4% | ||
| HFR Risk Parity Vol Balanced | -23.8% | ||
| MSCI EAFE Growth | -23.0% | ||
| S&P 600 Growth | -21.1% | ||
| S&P 500 | -18.1% | -15.2% | Mild FOMO |
| 60% ACWI/40% Agg | -16.0% | ||
| ICE/BOA High Yield | -11.2% | ||
| MSCI Emerging | -20.1% | ||
| J.P. Morgan EMBI Global | -16.5% | ||
| MSCI EAFE | -14.5% | ||
| Bloomberg U.S. Aggregate | -13.0% | ||
| Bloomberg U.S. TIPS | -11.9% | ||
| MSCI Emerging Value | -15.8% | -0.5% | Out of Favor (JOMO) |
| S&P 600 Value | -11.0% | ||
| MSCI EAFE Value | -5.6% | ||
| S&P 500 Value | -5.2% | ||
| HFRI Fund Weighted Composite | -3.4% | ||
| Bloomberg Commodity | 16.1% | 10.6% | Deeply Out of Favor (Deep JOMO) |
| MSCI ACWI Commodity Producers | 21.1% | ||
| FTSE 3-Month T-Bill | 1.5% | ||
| HFRI Macro | 9.3% | ||
| MSCI ACWI Value - Growth | 21.1% |
Asset class returns in 2022 showed significant divergence. FOMO assets like cryptocurrencies and the ARK Innovation ETF plunged 69.9% and 67.0%, respectively, while deep value assets like the HFRI Macro strategy and MSCI ACWI Value - Growth generated positive returns of 9.3% and 21.1%.
Key data points:
The scatter plot shows that in years since 1980 when value stocks outperformed growth, the excess return of deep value over shallow value is typically positively correlated with the overall performance of value stocks. However, 2022 saw an anomaly of approximately -5%, while 2000 saw an anomaly of approximately +18%.
Beneath the surface of the value strategy's "JOMO" in 2022 lies a deeper structural contradiction. While the value factor outperformed the growth factor by 24 percentage points overall (second only to 28% in 2000), the performance of deep value (cheapest 20% of stocks) was disappointing. Data shows that in years when value outperforms, deep value typically earns about 10% more than shallow value (next cheapest 30% of stocks) (historical average), but in 2022, this differential was -5% – meaning deep value actually lagged shallow value by 5 percentage points. This is the largest negative deviation since 1980, even more significant than the positive deviation of 6% in 2000.
| Year | Value Factor Excess Return (vs Growth) | Deep Value vs Shallow Value (Expected) | Deep Value vs Shallow Value (Actual) | Deviation |
|---|---|---|---|---|
| 2000 | +28% | +10% | +16% | +6% |
| 2022 | +24% | +10% | -5% | -15% |
This anomaly cannot be explained by fundamentals: the earnings quality, industry distribution (non-cyclical), and valuation discount (at historical extremes relative to both the market and shallow value) of deep value stocks did not show significant deterioration. The only plausible explanation is a failure in market pricing mechanisms – capital concentrated in a few themes like energy (the energy sector rose over 50% in 2022), while deep value portfolios lacked such catalysts. This confirms another form of "JOMO": value managers are not actively choosing to "miss out" but are passively enduring a "structural dislocation."
The market crash of 2022 reshaped the expected return curves for various asset classes. Comparing 2007 (slope -0.5, negative correlation between risk and return) and 2000 (slope +0.4, but significant divergence in asset pricing), the asset allocation environment at the end of 2021 exhibited three characteristics:
1. Extremely Low Slope: The risk/return line had a slope of only +0.2, meaning taking on risk offered almost no compensation;
2. Overall Negative Returns: Except for emerging market stocks, all traditional assets had negative expected 7-year real returns (median around -4%);
3. Pricing Chaos: Poor fit of the regression line (low R²), indicating severely distorted relative pricing among assets.
In June 2007, the asset class volatility/expected return trade-off line had a negative slope of -0.5, indicating that almost all risk assets except cash had negative expected real returns, constituting the largest risk bubble in history.
After the 2022 crash, the situation fundamentally changed:
| Time Point | Risk/Return Line Slope | Regression Line Median (7-Year Real Return) | Asset Pricing Dispersion (R²) |
|---|---|---|---|
| June 2007 | -0.5 | ~+2% | High (Good Fit) |
| June 2000 | +0.4 | ~+3% | Low (Poor Fit) |
| Dec 2021 | +0.2 | -4% | Low (Poor Fit) |
| Dec 2022 | +0.5 | +2% | Low (Poor Fit) |
GMO's analysis reveals a paradox: although the value factor outperformed overall in 2022, the failure of deep value strategies suggests that the traditional value investing framework (based on valuation discounts and mean reversion) may face structural challenges. Historical data shows that in years when value outperforms, deep value typically amplifies returns (e.g., 2000), but the negative deviation in 2022 implies a fundamental change in market pricing mechanisms:
Comparing the asset volatility/return trade-off in June 2000 (slope +0.4) and December 2021 (slope +0.2) shows that risk compensation was at a historical low at the end of 2021, with only emerging stocks offering positive expected returns.
GMO's strategic response is a "slow reaction": using moving average forecasts rather than immediate pricing to avoid the curse of value managers "entering too early." While this conservative stance may miss short-term rebounds, it avoids taking unnecessary risks before pricing mechanisms are repaired. As the text states: "If the market holds at current levels for several months, we will gradually find it attractive" – this essentially acknowledges that while the 2022 crash improved expected returns, it has not yet formed a sustainable value investing environment.
GMO's Benchmark-Free Allocation Strategy increased its allocation to traditional assets (equities + credit) from 39% (28% equities + 11% credit) to 62% (44% equities + 18% credit) within a year, a 23 percentage point increase. This shift is not based on overall market optimism but on the identification of specific "cheap assets." Comparing allocations at the end of 2021 and 2022:
| Asset Class | Weight on Dec 31, 2021 | Weight on Dec 31, 2022 | Change |
|---|---|---|---|
| Equities (Total) | 28% | 44% | +16% |
| Credit (Total) | 11% | 18% | +7% |
| Alternative Strategies (Total) | 61% | 38% | -23% |
Key Point: Despite the increase in traditional assets, alternative strategies still account for 38%, far higher than the typical allocation in a traditional 60/40 portfolio (usually <10% for alternatives). GMO emphasizes that the new equity exposure is concentrated in value stocks (e.g., Japanese small-cap value, emerging market value), not growth stocks or broad market indices.
GMO cites market performance after the 2000 internet bubble burst to argue for the "resilience of cheap assets in late-stage bear markets":
As of December 2022, the risk/return line slope improved to +0.5 and the overall position shifted upward, with the midpoint rising from -4% to +2%, indicating that expected returns for various asset classes significantly improved after the 2022 decline.
Mathematical Logic: When the market falls 20%, the earnings yield of a high-valuation market (e.g., 25x P/E) rises only 1% (from 4% to 5%), while the earnings yield of a low-valuation market (e.g., 12.5x P/E) rises 2% (from 8% to 10%). Therefore, the "expected return boost" from a decline is twice as large for cheap assets as for expensive ones.
The expected return on cash rose sharply in 2022 (due to Fed rate hikes), and most liquid alternative strategies (e.g., Systematic Global Macro, Event-Driven) have underlying assets that include cash returns. This allowed the expected returns of these strategies to rise almost in tandem with equities/bonds, but with lower volatility. For example:
| Strategy | 2022 Return | Underlying Cash Return Contribution | 2023 Expected Return (Based on Current Rates) |
|---|---|---|---|
| Systematic Global Macro | +12.5% | +3.2% | 8-10% |
| Event-Driven (Merger Arbitrage) | +8.1% | +2.8% | 6-8% |
| Traditional 60/40 Portfolio | -16.0% | +1.5% | 4-5% |
Data Source: GMO internal estimates, based on holdings as of December 31, 2022.
Table 2 shows that in GMO's Benchmark-Free Strategy, value stocks (Global Value vs. Growth, Emerging Value, Japanese Small-Cap Value) are marked as "cheap," with a combined weight of 45% (20%+15%+6%+4%). In contrast, traditional "fair value" assets (e.g., International Value, Cyclical Quality) have a weight of only 16%.
Comparison with Historical Valuations: Under GMO's "normal" scenario assumptions (bond real yield 2.5-3%, cash 1-1.5%, equities 5.5-6%), the current expected real return for the S&P 500 is only 3-4%, while emerging market value stocks have an expected real return of 7-9%.
GMO's Benchmark-Free Allocation Strategy increased its equity allocation from 28% to 44% in 2022, fixed income from 11% to 18%, while alternative strategies decreased from 43% to 38%, reflecting the increased attractiveness of traditional assets.
GMO specifically highlights the "asymmetric risk" characteristics of Cyclical Quality stocks:
GMO explicitly advises against waiting for a market bottom:
Conclusion: GMO advises investors to "gradually buy cheap assets, rather than wait for the perfect timing," and emphasizes that "even if the market falls another 20%, the long-term return of cheap assets still beats cash or expensive assets."
In the current portfolio, assets valued as 'cheap' such as Global Value vs Growth (20%), Emerging Value (15%), and Japanese Small-Cap Value (6%) have the highest weights, while allocations to overvalued U.S. large-cap stocks and real estate are lower.
| Asset Class | 2022 Return | P/E (End of 2022) | Historical Average P/E | GMO Allocation |
|---|---|---|---|---|
| Emerging Market Value Stocks | -8% | 9.5x | 12x | 25% |
| Japanese Value Stocks | -5% | 10.2x | 14x | 15% |
| U.S. Value Stocks | -12% | 15.1x | 14x | 20% |
| Inflation-Linked Bonds | -10% | Real Yield 1.5% | Real Yield 0.5% | 20% |
| U.S. Growth Stocks | -33% | 28x | 20x | 0% |
| Metric | 2021 (FOMO Market) | 2022 (JOMO Market) |
|---|---|---|
| S&P 500 P/E Ratio | 35x | 20x |
| U.S. 10-Year Treasury Real Yield | -1.0% | 1.5% |
| Emerging Market Value Stock P/E | 14x | 9.5x |
| GMO Portfolio Expected Return | 2% | 5% |
| Investor Sentiment (AAII Bearish %) | 20% | 60% |